<abstract xmlns="http://www.w3.org/1999/xhtml"><p>Dithiothreitol (DTT), a reducing reagent, has multiple applications in blood bank testing. DTT disrupts the bridging of the disulfide bonds between amino acid residues necessary for structural conformation of some proteins and the bonds holding an IgM molecule in the pentameric formation. DTT treatment of red blood cells (RBCs) can denature or modify certain blood group antigens—in particular, those in the Kell, Lutheran, YT, JMH, LW, Cromer, Indian, Dombrock, and Knops systems—and prevent recognition by the corresponding antibodies. It also destroys RBC CD38, allowing DTT-treated RBCs to be used to avoid testing interference by therapeutic anti-CD38 preparations. DTT treatment can be used to disperse spontaneous agglutination of RBCs caused by heavy IgM autoantibody coating that invalidates ABO/Rh cell grouping and direct antiglobulin tests. <italic><bold>Immunohematology</bold></italic><bold>2017;33:170–172.</bold></p></abstract>

Dithiothreitol (DTT), a reducing reagent, has multiple applications in blood bank testing. DTT disrupts the bridging of the disulfide bonds between amino acid residues necessary for structural conformation of some proteins and the bonds holding an IgM molecule in the pentameric formation. DTT treatment of red blood cells (RBCs) can denature or modify certain blood group antigens—in particular, those in the Kell, Lutheran, YT, JMH, LW, Cromer, Indian, Dombrock, and Knops systems—and prevent recognition by the corresponding antibodies. It also destroys RBC CD38, allowing DTT-treated RBCs to be used to avoid testing interference by therapeutic anti-CD38 preparations. DTT treatment can be used to disperse spontaneous agglutination of RBCs caused by heavy IgM autoantibody coating that invalidates ABO/Rh cell grouping and direct antiglobulin tests. Immunohematology2017;33:170–172.

Dithiothreitol treatment of red blood cells

Immunohematology

{"article-title":"Dithiothreitol treatment of red blood cells"}

Dithiothreitol (DTT), a reducing reagent, has multiple applications in blood bank testing. DTT disrupts the bridging of the disulfide bonds between amino acid...

Dithiothreitol treatment of red blood cells

Publié en ligne: 16 oct. 2019

Pages: 170 - 172

DOI: https://doi.org/10.21307/immunohematology-2019-025

Mots clés
dithiothreitol (DTT), indirect antiglobulin test, Kell system, daratumumab

© 2017 C.B. Bub published by Sciendo

Dithiothreitol treatment of red blood cells

Publié en ligne: 16 oct. 2019

Pages: 170 - 172

DOI: https://doi.org/10.21307/immunohematology-2019-025

Mots clésdithiothreitol (DTT), indirect antiglobulin test, Kell system, daratumumab

© 2017 C.B. Bub published by Sciendo

Mots clés
dithiothreitol (DTT), indirect antiglobulin test, Kell system, daratumumab